semaglutide vs tirzepatide doses Switching from Semaglutide to Tirzepatide:

Drug interactions are another critical consideration

These medications are administered subcutaneouslyinto the fatty tissue layer beneath the skinrather than intramuscularly or intravenously

doi: 10.3785/j.issn.1008-9292.2013.02.008, 131

Tirzepatide (15 mg weekly) drives 15.7% weight loss over 72 weeks in patients with obesity and T2D (45) and 22.5% weight loss in patients with obesity alone (46)

"While Health Canada cannot confirm when submissions are filed by a manufacturer, the department does post regular updates about submissions that have been accepted for review on the Submissions Under Review list," the regulator responded on Wednesday